ResMed Inc (ASX: RMD) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ResMed Inc Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $41.01 billion
P/E Ratio 30.80
Dividend Yield 0.98%
Shares Outstanding 1.47 billion
Earnings per share 0.604
Dividend per share 0.29
Year To Date Return 13.81%
Earnings Yield 3.25%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ResMed Inc (ASX: RMD)
    Latest News

    A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    Brokers gave the thumbs up to these ASX shares last week. Why are they bullish?

    Read more »

    Three business people join hands in strength and unity
    Dividend Investing

    3 ASX All Ords shares with ex-dividend dates in the next week

    These All Ords shares are about to cough up some cash for shareholders.

    Read more »

    a woman and a man sleep side by side with the woman placing a hand on the man's chest while he wears a sleep breathing machine.
    Growth Shares

    Will you miss out if you don't buy more of this superstar ASX 200 growth stock?

    This former market darling had a rough 2023, but its early performance in 2024 is very encouraging.

    Read more »

    A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
    Healthcare Shares

    ResMed shares rise on major Philips news

    This sleep treatment company's rival will be MIA in the US for a while longer.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
    Broker Notes

    Leading brokers name 3 ASX shares to buy today

    Here's why brokers believe that now could be the time to snap up these shares.

    Read more »

    a woman holds her hands up in delight as she sits in front of her lap
    Healthcare Shares

    Why it isn't too late to buy ResMed shares

    Goldman Sachs believes this top stock could keep climbing.

    Read more »

    A man looking at his laptop and thinking.
    Share Market News

    5 things to watch on the ASX 200 on Monday

    A decent session is expected for Aussie investors today.

    Read more »

    Father in the ocean with his daughters, symbolising passive income.
    Investing Strategies

    Here's how I'm targeting a generous ASX passive income in retirement!

    Many ordinary folks could quit work with a decent flow of cash, if only they invested wisely in stocks.

    Read more »

    Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
    Share Market News

    Here are the top 10 ASX 200 shares today

    The ASX 200 finished up the week on a high this Thursday...

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Incitec Pivot, Mineral Resources, Patriot Battery Metals, and ResMed shares are racing higher

    These ASX shares are ending the week strongly. But why?

    Read more »

    A man sees some good news on his phone and gives a little cheer.
    Healthcare Shares

    ResMed share price jumps almost 7% on stellar quarterly performance

    ResMed shareholders will be sleeping soundly tonight after this update.

    Read more »

    Man sits smiling at a computer showing graphs
    Earnings Results

    ResMed shares on watch after smashing Q2 expectations

    This sleep treatment company was in fine form during the second quarter.

    Read more »

    Frequently Asked Questions

    Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.

    Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    07 Feb 2024 $0.0517 0.00% Interim 14 Mar 2024
    08 Nov 2023 $0.0528 0.00% Interim 14 Dec 2023
    16 Aug 2023 $0.0524 0.00% Final 21 Sep 2023
    10 May 2023 $0.0460 0.00% Interim 15 Jun 2023
    08 Feb 2023 $0.0444 0.00% Interim 16 Mar 2023
    09 Nov 2022 $0.0466 0.00% Interim 15 Dec 2022
    17 Aug 2022 $0.0445 0.00% Final 22 Sep 2022
    11 May 2022 $0.0429 0.00% Interim 16 Jun 2022
    09 Feb 2022 $0.0410 0.00% Interim 17 Mar 2022
    10 Nov 2021 $0.0403 0.00% Interim 16 Dec 2021
    18 Aug 2021 $0.0412 0.00% Final 23 Sep 2021
    12 May 2021 $0.0354 0.00% Interim 17 Jun 2021
    10 Feb 2021 $0.0352 0.00% Interim 18 Mar 2021
    11 Nov 2020 $0.0378 0.00% Interim 17 Dec 2020
    19 Aug 2020 $0.0379 0.00% Final 24 Sep 2020
    13 May 2020 $0.0423 0.00% Interim 18 Jun 2020
    12 Feb 2020 $0.0406 0.00% Interim 19 Mar 2020
    06 Nov 2019 $0.0396 0.00% Interim 12 Dec 2019
    14 Aug 2019 $0.0403 0.00% Final 19 Sep 2019
    08 May 2019 $0.0371 0.00% Interim 13 Jun 2019
    06 Feb 2019 $0.0365 0.00% Interim 14 Mar 2019
    07 Nov 2018 $0.0356 0.00% Interim 13 Dec 2018
    15 Aug 2018 $0.0357 0.00% Final 20 Sep 2018
    09 May 2018 $0.0326 0.00% Interim 14 Jun 2018
    07 Feb 2018 $0.0315 0.00% Interim 15 Mar 2018
    08 Nov 2017 $0.0320 0.00% Interim 14 Dec 2017
    16 Aug 2017 $0.0308 0.00% Final 21 Sep 2017
    10 May 2017 $0.0313 0.00% Interim 15 Jun 2017
    08 Feb 2017 $0.0303 0.00% Interim 16 Mar 2017
    09 Nov 2016 $0.0303 0.00% Interim 15 Dec 2016
    17 Aug 2016 $0.0300 0.00% Final 22 Sep 2016
    18 May 2016 $0.0291 0.00% Interim 16 Jun 2016
    09 Feb 2016 $0.0295 0.00% Interim 17 Mar 2016
    17 Nov 2015 $0.0292 0.00% Interim 17 Dec 2015

    RMD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ResMed Inc

    ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.

    It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.

    RMD Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    18 Apr 2024 $27.63 $-1.25 -4.33% 7,438,244 $27.38 $27.96 $27.05
    17 Apr 2024 $28.88 $0.19 0.66% 858,793 $28.81 $29.00 $28.80
    16 Apr 2024 $28.69 $-0.10 -0.35% 4,970,314 $28.61 $28.82 $28.53
    15 Apr 2024 $28.79 $-0.41 -1.40% 1,186,393 $28.88 $28.93 $28.64
    12 Apr 2024 $29.20 $-0.36 -1.22% 958,430 $29.00 $29.29 $28.91
    11 Apr 2024 $29.56 $0.43 1.48% 2,767,253 $29.50 $29.75 $29.43
    10 Apr 2024 $29.13 $0.62 2.17% 1,514,842 $29.15 $29.49 $29.13
    09 Apr 2024 $28.51 $-0.28 -0.97% 1,058,202 $28.56 $28.58 $28.40
    08 Apr 2024 $28.79 $0.32 1.12% 820,776 $28.70 $28.91 $28.65
    05 Apr 2024 $28.47 $-0.07 -0.25% 1,663,666 $28.13 $28.53 $28.01
    04 Apr 2024 $28.54 $-0.11 -0.38% 1,714,746 $28.59 $28.60 $28.40
    03 Apr 2024 $28.65 $-0.59 -2.02% 1,812,741 $28.44 $28.76 $28.25
    02 Apr 2024 $29.24 $-0.91 -3.02% 2,007,853 $29.27 $29.27 $29.02
    28 Mar 2024 $30.15 $0.22 0.74% 2,158,925 $30.14 $30.21 $29.98
    27 Mar 2024 $29.93 $0.58 1.98% 1,910,650 $29.53 $29.96 $29.50
    26 Mar 2024 $29.35 $-0.32 -1.08% 1,061,119 $29.58 $29.60 $29.26
    25 Mar 2024 $29.67 $-0.04 -0.13% 1,392,429 $29.62 $29.78 $29.48
    22 Mar 2024 $29.71 $0.36 1.23% 1,188,409 $29.45 $29.82 $29.37
    21 Mar 2024 $29.35 $0.16 0.55% 3,134,158 $29.69 $29.80 $29.30
    20 Mar 2024 $29.19 $0.03 0.10% 1,529,404 $29.41 $29.50 $29.09

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Peter Craig Farrell Non-Executive DirectorNon-Executive Chairman Jul 2002
    No profile reported in Annual Report.
    Mr Ronald R Taylor Non-Executive Director Jan 2005
    Mr Taylor is a director of Actavis, Inc. and Red Lion Hotels Corp. From 2002 until his appointment to the ResMed board in 2005, he served as chairman of the ResMed Foundation. In 1987, Mr. Taylor founded Pyxis Corporation where he served as chairman, president, and chief executive officer until its purchase by Cardinal Health, Inc., in 1996.
    Mr Richard Sulpizio Non-Executive Director Aug 2005
    Mr Sulpizio has served as president and chief executive officer of Qualcomm Enterprise Services. He currently serves as a senior advisor to Qualcomm Enterprise Services. Mr Sulpizio held various positions with Qualcomm during his 20-year tenure there, including president and chief operating officer. He served as a member of Qualcomm's board of directors from 2000 until 2007.
    Mr Michael J Farrell Chief Executive OfficerExecutive Director Mar 2013
    Mr Farrell was foundation director of Biomedical Engineering at the University of New South Wales where he currently serves as a visiting professor and as chairman of the UNSW Centre for Innovation and Entrepreneurship. Since 2005, Dr Farrell has been a director of NuVasive, Inc. He also serves as the non-executive chair of QRxPharma.
    Ms Carol Burt Non-Executive Director Aug 2014
    No profile reported in Annual Report.
    Ms Karen Ruth Drexler Non-Executive Director Nov 2017
    No profile reported in Annual Report.
    Mr Jan De Witte Non-Executive Director May 2019
    Mr De Witte is the chief executive officer and member of the board of directors of Barco NV.
    Ms Harjit Gill Non-Executive Director Nov 2018
    No profile reported in Annual Report.
    Mr John Hernandez Non-Executive Director Nov 2021
    No profile reported in Annual Report.
    Mr Desney Tan Non-Executive Director Nov 2021
    No profile reported in Annual Report.
    Brett A. Sandercock Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 Shareholder 0 0.00%

    Profile

    since

    Note